Donepezil - Shanghai Synergy Pharmaceutical Sciences
Alternative Names: Donepezil dihydroxynaphthalate - Shanghai Synergy Pharmaceutical Sciences; HHT-201Latest Information Update: 03 May 2024
At a glance
- Originator Shanghai Synergy Pharmaceutical Sciences
- Class Antidementias; Indans; Nootropics; Piperidines; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease
Most Recent Events
- 24 Apr 2024 Preclinical trials in Alzheimer's disease in China (IM)
- 24 Apr 2024 Shanghai Synergy Pharmaceutical Sciences plans a phase I trial for Alzheimer's disease (In volunteers) in China (IM), in June 2024 (NCT06373094)